LIVE: House hearing on Dengvaxia
Analysis of clinical data showed Sanofi Pasteur's Dengvaxia poses more risks for people who have not been infected by the virus before immunization.
More than 700,000 Filipino children in Luzon have been given the dengue vaccine under the government's immunization program, according to the Department of Health. – Rappler.com
February 5, 2018